Drugs that target dynamic microtubules: a new molecular perspective.
Reads0
Chats0
TLDR
The effects of microtubule‐binding chemotherapeutic agents are reviewed from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of micro Tubule assembly or disassembly.Abstract:
Microtubules have long been considered an ideal target for anticancer drugs because of the essential role they play in mitosis, forming the dynamic spindle apparatus. As such, there is a wide variety of compounds currently in clinical use and in development that act as antimitotic agents by altering microtubule dynamics. Although these diverse molecules are known to affect microtubule dynamics upon binding to one of the three established drug domains (taxane, vinca alkaloid, or colchicine site), the exact mechanism by which each drug works is still an area of intense speculation and research. In this study, we review the effects of microtubule-binding chemotherapeutic agents from a new perspective, considering how their mode of binding induces conformational changes and alters biological function relative to the molecular vectors of microtubule assembly or disassembly. These “biological vectors” can thus be used as a spatiotemporal context to describe molecular mechanisms by which microtubule-targeting drugs work.read more
Citations
More filters
Journal ArticleDOI
Carbon nanotubes for delivery of small molecule drugs
Bin Sheng Wong,Sia Lee Yoong,Anna Jagusiak,Tomasz Panczyk,Han Kiat Ho,Wee Han Ang,Giorgia Pastorin +6 more
TL;DR: The delivery of small molecule drugs is expounded, with special attention paid to the current progress of in vitro and in vivo research involving CNT-based DDSs, before finally concluding with some consideration on inevitable complications that hamper successful disease intervention with CNTs.
Journal ArticleDOI
Photoswitchable Inhibitors of Microtubule Dynamics Optically Control Mitosis and Cell Death
Malgorzata Borowiak,Malgorzata Borowiak,Wallis Nahaboo,Martin Reynders,Katharina Nekolla,Pierre Jalinot,Jens Hasserodt,Markus Rehberg,Marie Delattre,Stefan Zahler,Angelika M. Vollmar,Dirk Trauner,Oliver Thorn-Seshold,Oliver Thorn-Seshold +13 more
TL;DR: The photostatins are introduced, inhibitors that can be switched on and off in vivo by visible light, to optically control microtubule dynamics and are promising as a new class of precision chemotherapeutics whose toxicity may be spatiotemporally constrained using light.
Journal ArticleDOI
Plant-derived Immunomodulators: An Insight on Their Preclinical Evaluation and Clinical Trials
TL;DR: The present review will give an overview of widely investigated plant-derived compounds which have exhibited potent effects on cellular and humoral immune functions in pre-clinical investigations and will highlight their clinical potential.
Journal ArticleDOI
Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites
TL;DR: The identified plants and compounds offer a chance to develop new drugs against parasitic diseases and need to be tested in more detail, especially in animal models and if successful, in clinical trials.
Journal ArticleDOI
Plant-Derived Anti-Inflammatory Compounds: Hopes and Disappointments regarding the Translation of Preclinical Knowledge into Clinical Progress
Robert Fürst,Ilse Zündorf +1 more
TL;DR: This minireview will summarize the current situation of 6 very prominent plant-derived anti-inflammatory compounds: curcumin, colchicine, resveratrol, capsaicin, epigallocatechin-3-gallate (EGCG), and quercetin, and sum up the planned trials in order to provide insights into the inflammatory disorders that are hypothesized to be beneficially influenced by the compound.
References
More filters
Journal Article
Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents
Maria Ines Nicoletti,Giorgio Valoti,Paraskevi Giannakakou,Zhirong Zhan,Jon-Hyeok Kim,Valeria Lucchini,Fabio Landoni,Joseph G. Mayo,Raffaella Giavazzi,Tito Fojo +9 more
TL;DR: The results suggest that altered expression of specific beta-tubulin isotypes may not play a significant role in paclitaxel sensitivity in vivo and argue against a possible significance in a clinical setting.
Journal ArticleDOI
Pharmacokinetic properties of noscapine
TL;DR: There was no pharmacokinetic evidence to support a prolonged action of the ion exchange resin tablet and the absolute oral bioavailability was 30%, with a 3.6-fold interindividual variation.
Journal ArticleDOI
Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye.
Kazuyasu Fujii,Kazuyasu Fujii,Tadashi Kondo,Hideki Yokoo,Tesshi Yamada,Keiji Iwatsuki,Setsuo Hirohashi +6 more
TL;DR: Western blotting with specific antibodies revealed the overexpression of PCNA, EB1 and E‐FABP in HCC tissues compared with noncancerous tissues.
Journal ArticleDOI
Decreasing oncoprotein 18/stathmin levels reduces microtubule catastrophes and increases microtubule polymer in vivo.
TL;DR: Microinjection of anti-Op18 antibodies or antisense oligonucleotides to block either Op18 activity or expression in interphase newt lung cells are consistent with Op18 functioning to regulate microtubule catastrophes during interphase in vivo.
Journal ArticleDOI
Microtubule-associated proteins and microtubule-based translocators have different binding sites on tubulin molecule
TL;DR: It is shown that microtubules composed of tubulin whose 4-kDa C-terminal domain was cleaved by subtilisin are unable to bind MAPs but can still bind the anterograde translocator protein kinesin and the retrograde translocators dynein.
Related Papers (5)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet,Mary Ann Jordan +1 more